Osteoarthritis Flashcards
What is osteoarthritis?
Joint failure/pathologic changes in all joint structures with hyaline articular cartilage loss, thickening/sclerosis of bony plates, outgrowth of osteophytes at joint margins, articular capsule stretching, mild synovitis, and weakness in muscles bridging joints
What are systemic risk factors for OA?
Older age, female sex, genetic factors, excess body weight, certain occupations, elite athletic activity
What are local risk factors for OA?
Major injury, meniscectomy, developmental abnormalities, varus alignment, meniscal tear/meniscal extrusion
What are occupational risk factors for OA?
Knee - heavy lifting, mining
Hip - farming
Elbow - jackhammer operator
Hand - cotton mill
What is the natural history of OA?
Some joints will not progress, others will have phases of compensation (remodeling) and decompensation (more insult than repair)
What are the constituents of healthy cartilage type II?
- type II cartilage collagen fibrils
- aggrecan
- ECM proteins
- chondrocytes
What is the function of aggrecans?
Proteoglycans that link with hyaluronic acid and retain water to give cartilage compressive stiffness
What is the function of chondrocytes?
Cartilage cells that synthesize elements of the matrix, produce cytokines/growth factors/enzymes
What are the main proteinases involved in cartilage destruction of OA?
Matrix metalloproteinases
What controls the function of MMPs?
TIMPs (tissue inhibitors of MMPs)
What are the stages of cartilage pathology in OA?
surface fibrillation and irregularity –> full-thickness defect to the bone –> cartilage damage/loss to bare bone
What pathological changes occur in bones in OA?
Thickening/stiffening of subchondral plate and osteocyte formation in joint margins
What pathological changes occur in the synovium in OA?
Can become edematous and inflamed (but not as much as inflammatory joint pains)
What pathological changes occur int he joint capsule in OA?
Edema, later fibrosis
What is phase 1 of OA?
- edema of ECM
- microcracks on cartilage
- focal loss of chondrocytes, alternating with areas of proliferation